文献速递肿瘤 PET/CT

通过[18F]FDG PET/CT鉴别胸腺囊肿与低风险胸腺瘤

Distinguishing thymic cysts from low-risk thymomas via [18F]FDG PET/CT.
PubMed 文献 · EJNMMI Res · 2024-05-03

回顾性分析70例胸腺肿块患者(胸腺囊肿18例、低风险胸腺瘤52例)术前[18F]FDG PET/CT,评估视觉表现与定量参数对两者的鉴别价值。PET SUVmax的AUC为0.996,以≤2.1为阈值时灵敏度100.0%、特异度94.2%,其AUC显著大于CT直径和CT HU。结论认为低FDG摄取(SUVmax≤2.1,等于或低于纵隔)是胸腺囊肿的强诊断标志。

要点

  • PET视觉分级和中央代谢缺损在胸腺囊肿与低风险胸腺瘤间差异显著(均P<0.001)。
  • PET SUVmax的AUC为0.996,以≤2.1为阈值时灵敏度100.0%、特异度94.2%。
  • PET SUVmax的AUC显著大于CT直径(P=0.009)和CT HU(P=0.004)。

核心结论

  • 在评估的[18F]FDG PET/CT参数中,低FDG摄取(SUVmax≤2.1,等于或低于纵隔)是胸腺囊肿的强诊断标志。
  • PET视觉分级和中央代谢缺损是易于获取的鉴别表现。

研究设计与样本

  • 回顾性分析术前接受[18F]FDG PET/CT后行胸腺切除术的胸腺肿块患者。
  • 最终纳入70例患者,其中胸腺囊肿18例、低风险胸腺瘤52例。

主要发现

  • PET视觉分级(P<0.001)和PET中央代谢缺损(P<0.001)在胸腺囊肿与低风险胸腺瘤间差异显著,CT形状则无显著差异。
  • 定量参数PET SUVmax(P<0.001)、CT直径(P<0.001)和CT HU(P=0.004)在两组间差异显著。
  • ROC分析中PET SUVmax的AUC为0.996(P<0.001),以≤2.1为阈值时灵敏度100.0%、特异度94.2%。
  • PET SUVmax的AUC显著大于CT直径(P=0.009)和CT HU(P=0.004)。

关键数值与推荐

  • PET SUVmax≤2.1(等于或低于纵隔)作为胸腺囊肿的诊断阈值,灵敏度100.0%、特异度94.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thymic cysts are a rare benign disease that needs to be distinguished from low-risk thymoma. [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is a non-invasive imaging technique used in the differential diagnosis of thymic epithelial tumours, but its usefulness for thymic cysts remains unclear. Our study evaluated the utility of visual findings and quantitative parameters of [18F]FDG PET/CT for differentiating between thymic cysts and low-risk thymomas. METHODS: Patients who underwent preoperative [18F]FDG PET/CT followed by thymectomy for a thymic mass were retrospectively analyzed. The visual [18F]FDG PET/CT findings evaluated were PET visual grade, PET central metabolic defect, and CT shape. The quantitative [18F]FDG PET/CT parameters evaluated were PET maximum standardized uptake value (SUVmax), CT diameter (cm), and CT attenuation in Hounsfield units (HU). Findings and parameters for differentiating thymic cysts from low-risk thymomas were assessed using Pearson's chi-square test, the Mann-Whitney U-test, and receiver operating characteristics (ROC) curve analysis. RESULTS: Seventy patients (18 thymic cysts and 52 low-risk thymomas) were finally included. Visual findings of PET visual grade (P < 0.001) and PET central metabolic defect (P < 0.001) showed significant differences between thymic cysts and low-risk thymomas, but CT shape did not. Among the quantitative parameters, PET SUVmax (P < 0.001), CT diameter (P < 0.001), and CT HU (P = 0.004) showed significant differences. In ROC analysis, PET SUVmax demonstrated the highest area under the curve (AUC) of 0.996 (P < 0.001), with a cut-off of equal to or less than 2.1 having a sensitivity of 100.0% and specificity of 94.2%. The AUC of PET SUVmax was significantly larger than that of CT diameter (P = 0.009) and CT HU (P = 0.004). CONCLUSIONS: Among the [18F]FDG PET/CT parameters examined, low FDG uptake (SUVmax ≤ 2.1, equal to or less than the mediastinum) is a strong diagnostic marker for a thymic cyst. PET visual grade and central metabolic defect are easily accessible findings.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Choi S, Kim YI, Han S, et al. Distinguishing thymic cysts from low-risk thymomas via [18F]FDG PET/CT. EJNMMI Res. 2024. PMID: 38702532. doi:10.1186/s13550-024-01108-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。